Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1298, pseudogene (RNU6-1298P) is a non-coding RNA pseudogene in the human genome[1][5]. As a member of the U6 small nuclear RNA family, it does not encode a protein and its transcript is not considered functional in canonical RNA processing. Pseudogenes such as RNU6-1298P are generally regarded as non-functional genomic elements, though evolving research has identified some pseudogenes as modulators of gene expression via RNA interference, serving as potential competitive endogenous RNAs (ceRNAs), and occasionally acting as decoys for microRNAs or RNA binding proteins[2][4]. There is no current evidence that RNU6-1298P has such activities or plays a direct disease role. No drugs target this locus and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1298, pseudogene (RNU6-1298P).